Unveiling Three Undiscovered Gems in Asia with Strong Potential

Amidst a backdrop of geopolitical tensions and fluctuating oil prices, Asian markets have demonstrated resilience, with certain sectors showing promise despite broader global challenges. In this dynamic environment, identifying stocks that exhibit strong fundamentals and adaptability to shifting economic conditions can uncover potential opportunities for investors seeking growth in the region.

Top 10 Undiscovered Gems With Strong Fundamentals In Asia

Name	Debt To Equity	Revenue Growth	Earnings Growth	Health Rating
Ad-Sol Nissin	NA	7.22%	15.60%	★★★★★★
Chongqing Machinery & Electric	18.92%	8.39%	25.87%	★★★★★★
Taiyo KagakuLtd	0.68%	6.49%	11.88%	★★★★★★
Xinxiang Chemical Fiber	70.11%	-0.33%	-29.16%	★★★★★☆
Forth Smart Service	44.85%	-3.80%	10.19%	★★★★★☆
Shanghai Fudan Microelectronics Group	16.49%	9.29%	-6.62%	★★★★★☆
Sing Investments & Finance	0.10%	5.85%	7.00%	★★★★☆☆
Shengda ResourcesLtd	57.58%	8.61%	9.90%	★★★☆☆☆
Primo Global Holdings	70.93%	9.87%	28.79%	★★★☆☆☆
HANA Micron	137.37%	21.15%	26.62%	★★★☆☆☆

Click here to see the full list of 116 stocks from our Asian Undiscovered Gems With Strong Fundamentals screener.

We'll examine a selection from our screener results.

Wuhan Hvsen BiotechnologyLtd (SZSE:300871)

Simply Wall St Value Rating: ★★★★★☆

Overview: Wuhan Hvsen Biotechnology Co., Ltd. engages in the research, development, and manufacture of macrolides APIs and preparations both in China and internationally, with a market cap of CN¥4.27 billion.

Operations: Wuhan Hvsen Biotechnology generates revenue primarily from its pharmaceuticals segment, amounting to CN¥1.72 billion. The company's financial performance is highlighted by a net profit margin trend that warrants consideration when evaluating its profitability.

Wuhan Hvsen Biotechnology has shown impressive growth, with earnings surging 129.5% over the past year, significantly outpacing the pharmaceutical industry's -3%. Its revenue for the first half of 2026 reached CN¥864.93 million, up from CN¥822.2 million a year earlier, while net income rose to CN¥205.76 million from CN¥117.18 million in the same period last year. The company is trading at a substantial discount of 94.8% below its estimated fair value and recently completed a share buyback worth CN¥29.48 million for 1,343,400 shares or about 0.67% of its outstanding shares.

• Click here and access our complete health analysis report to understand the dynamics of Wuhan Hvsen BiotechnologyLtd.

• Examine Wuhan Hvsen BiotechnologyLtd's past performance report to understand how it has performed in the past.

JirFine Intelligent Equipment (SZSE:301603)

Simply Wall St Value Rating: ★★★★★★

Overview: JirFine Intelligent Equipment Co., Ltd. is involved in the research, development, production, and sale of CNC machine tools both in China and internationally, with a market cap of CN¥14.41 billion.

Operations: JirFine derives its revenue primarily from the sale of CNC machine tools. The company focuses on both domestic and international markets for its products.

JirFine Intelligent Equipment has shown impressive growth, with earnings surging 65.1% last year, outpacing the Machinery industry's modest 0.2%. The company reported a net income of CNY 273.29 million for H1 2026, up from CNY 178.98 million in the same period last year, boosting basic earnings per share to CNY 2.26 from CNY 1.48. Trading at a significant discount of about 55% below estimated fair value and maintaining more cash than total debt highlights its financial prudence and potential value proposition for investors seeking opportunities in Asia's dynamic market landscape despite recent share price volatility over three months.

• Click to explore a detailed breakdown of our findings in JirFine Intelligent Equipment's health report.

• Gain insights into JirFine Intelligent Equipment's historical performance by reviewing our past performance report.

gremsInc (TSE:3150)

Simply Wall St Value Rating: ★★★★★★

Overview: grems, Inc. operates in Japan, focusing on energy solutions and electricity retailing, with a market capitalization of ¥56.01 billion.

Operations: The company generates revenue primarily through its Energy Solutions Business and Retail Electricity Business, with the latter contributing ¥20.16 billion.

With a promising trajectory, gremsInc. has seen its earnings grow at 25% annually over the past five years, although recent growth of 9% slightly lags behind the industry average of 9.7%. The company is trading at a compelling value, priced 50.8% below its estimated fair value. Its debt-to-equity ratio has improved from 30.5 to 17.1 over five years, indicating prudent financial management and reduced leverage risk. With high-quality earnings and positive free cash flow, gremsInc.'s financial health appears robust as it prepares to release Q1 results in August this year.

• Get an in-depth perspective on gremsInc's performance by reading our health report here.

• Evaluate gremsInc's historical performance by accessing our past performance report.

Summing It All Up

• Unlock our comprehensive list of 116 Asian Undiscovered Gems With Strong Fundamentals by clicking here.
• Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments.
• Enhance your investing ability with the Simply Wall St app and enjoy free access to essential market intelligence spanning every continent.

Curious About Other Options?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com